Deep Vein Thrombosis
📧 Sign up to get email alerts when something new happens for Deep Vein Thrombosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-01-15FDA Approved: PRADAXA — Supplemental Application (Boehringer Ingelheim Pharmaceuticals Inc.)
The FDA approved a supplemental application for Pradaxa (dabigatran etexilate mesylate) submitted by Boehringer Ingelheim Pharmaceuticals In…
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: Extended Out-of-hospital Low-molecular-weight Heparin Prophylaxis Against DVT and PE in Patients Undergoing Major Lung Resection
A completed clinical trial evaluating extended out-of-hospital prophylaxis with low-molecular-weight heparin to prevent deep vein thrombosis…
-
CLINICAL_TRIALS trial_result · 2014-12-17Clinical Trial Update: ODiXahip - a Phase IIa Dose Escalating Proof of Principle Trial [Phase 2]
The document summarizes Bayer's completed Phase IIa dose-escalation proof-of-principle trial of ODiXahip for the prevention of venous thromb…
-
CLINICAL_TRIALS trial_result · 2014-11-21Clinical Trial Update: The Impact of Laparoscopic Versus Open Surgeries on the Incidence of Postoperative Deep Vein Thrombosis in Patients With Gastrointestinal Malignancy ---A Cohort Study
A cohort study compares laparoscopic versus open surgery in patients with gastrointestinal neoplasms and assesses postoperative deep vein th…
-
CLINICAL_TRIALS research · 2014-11-19Clinical Trial Update: Prevention of Recurrence After Thrombolysis in Acute Iliofemoral Venous Thrombosis (PRAIS) Study [NA]
ClinicalTrials.gov update for the PRAIS study, which investigates prevention of recurrence after thrombolysis in acute iliofemoral deep vein…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein Thrombosis [Phase 2]
Phase 2 study update of BAY59-7939 (rivaroxaban), an oral direct Factor Xa inhibitor, in patients with acute symptomatic deep-vein thrombosi…
-
CLINICAL_TRIALS trial_result · 2014-10-27Clinical Trial Update: Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). A Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement. [Phase 3]
Phase 3 study of rivaroxaban (BAY 59-7939) for prevention of venous thromboembolism in adults undergoing elective total knee replacement has…
-
CLINICAL_TRIALS trial_result · 2014-10-22Clinical Trial Update: Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer [NA]
A completed clinical trial evaluating thromboprophylaxis for patients undergoing surgical resection for colon cancer, focusing on preventing…
-
CLINICAL_TRIALS trial_result · 2014-10-21Clinical Trial Update: Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH) [NA]
A completed clinical trial comparing Continuous Enhanced Circulation Therapy (CECT) with low molecular weight heparin (LMWH) for prevention …
-
CLINICAL_TRIALS trial_result · 2014-08-18Clinical Trial Update: The SOX Trial: Compression Stockings to Prevent the Post-Thrombotic Syndrome [Phase 3]
A Phase 3 trial (SOX) evaluating compression stockings to prevent post-thrombotic syndrome in deep vein thrombosis has completed, with resul…
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Study on Thrombosis Therapy in German Cancer Patients
A completed clinical trial evaluating a thrombosis therapy in German cancer patients, including cases of deep vein thrombosis and pulmonary …
-
FDA approval · 2014-06-23FDA Approved: ENOXAPARIN SODIUM — Original Application (Italfarmaco SpA)
FDA approved the original application for ENOXAPARIN SODIUM (enoxaparin sodium) submitted by Italfarmaco SpA under an ANDA. The approval con…
-
CLINICAL_TRIALS trial_result · 2014-06-13Clinical Trial Update: Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer [Phase 2]
Phase 2 trial evaluating rivaroxaban for treatment of deep vein thrombosis in patients using a strong CYP3A4 inducer; results were completed…
-
FDA approval · 2014-06-12FDA Approved: HEPARIN SODIUM — Original Application (Sandoz Inc.)
FDA approved Sandoz Inc.'s original application for generic heparin sodium, an injectable anticoagulant used to prevent and treat thrombotic…
-
FDA approval · 2014-05-29FDA Approved: HEPARIN SODIUM — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Heparin Sodium (Hospira, Inc.), updating the approved generic product under the ANDA program.
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3) [Phase 3]
A Phase 3 trial update (ADVANCE-3) reports results from an investigational drug intended to prevent thrombosis after hip replacement. The st…
-
CLINICAL_TRIALS trial_result · 2014-05-13Clinical Trial Update: Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery [Phase 3]
A Phase 3 trial evaluating an investigational drug to prevent thrombosis-related events after knee replacement has completed, with results p…
-
CLINICAL_TRIALS trial_result · 2014-05-06Clinical Trial Update: Coagulation Changes in Trauma Patients
A completed University of Miami clinical trial examining changes in coagulation among trauma patients with deep vein thrombosis.
-
CLINICAL_TRIALS trial_result · 2014-04-10Clinical Trial Update: Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism [Phase 3]
Phase 3 study results report the efficacy and safety of apixaban for treating deep vein thrombosis or pulmonary embolism.
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: Microplasmin Administered Via the Trellis-8 Infusion System for Treatment of Acute Iliofemoral DVT [Phase 2]
A Phase 2 trial evaluating microplasmin delivered via the Trellis-8 infusion system for acute iliofemoral deep vein thrombosis was terminate…
-
CLINICAL_TRIALS withdrawal · 2014-03-20Clinical Trial Update: Prolongation of the Interval Between Prothrombin Time Tests in Stable Patients II [Phase 3]
A Phase 3 trial evaluating prolongation of the interval between prothrombin time tests in stable patients with atrial fibrillation and valvu…
-
FDA approval · 2014-03-19FDA Approved: FONDAPARINUX SODIUM — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental ANDA for Fondaparinux sodium from Dr. Reddy's Laboratories Limited, authorizing the generic product to be market…
-
FDA approval · 2014-03-06FDA Approved: XARELTO — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for XARELTO (rivaroxaban) submitted by Janssen Pharmaceuticals, Inc. This action approves changes re…
-
FDA approval · 2013-11-15FDA Approved: ARIXTRA — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for ARIXTRA (fondaparinux sodium) submitted by Mylan Institutional LLC.
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Improving Lower Limb Blood Flow in Healthy Adult Volunteers [EARLY_Phase 1]
This early Phase 1 clinical trial update reports a study evaluating methods to improve lower limb blood flow in healthy adult volunteers in …